Article of the Month – July 2023
July 1, 2023
Wearable Devices
July 1, 2023Sophia Genetics
Overview
SOPHiA GENETICS combines extensive life sciences and medical fields knowledge with advanced data computing capabilities. Their goal is to bring data analytics tools to the market so that healthcare providers can benefit from the potential of Data-Driven Medicine. SOPHiA was created using statistical inference, pattern recognition, and machine learning (ML) techniques. This allows SOPHiA to unite experts in a gold-standard health-tech forum and encourage professional information exchange for long-term patient effects.
AI Aspects
SOPHiA AI maximizes the importance of genomics and radiomics data by combining statistical inference, pattern recognition, and ML. SOPHiA is a genuinely unique AI thanks to its extensive expertise with life science technology and accessibility to millions of diverse and nuanced data sets.
SOPHiA’s excellent capacity to address complex problems is ideal for identifying the signal in the noise and characterizing actionable results to help decision-makers make better decisions. Geneticists, pathologists, and radiologists in over 990 leading hospitals worldwide have embraced and trusted SOPHiA.
SOPHiA Radiomics
Radiomics converts traditional medical imaging into usable data that can be interpreted for better precision medicine decision support. Radiomic analyses can improve diagnostic accuracy, prognosis estimates, and treatment response forecasts in the future. SOPHiA Radiomics Solutions provide robust workflows for a wide range of research applications.
SOPHiA For Genomics
From tailored to complete genome applications, SOPHiA for Genomics provides clinical-grade genomic solutions to help experts reliably identify and characterize genetic variations associated with cancers and inherited disorders.
SOPHiA For clinical trials
SOPHiA for Clinical Trials gives clinical science a new lease on life and speeds up the discovery of new treatments. Thanks to this creative approach and our growing global clinical research community, SOPHiA can bind patients to the correct trials, advance therapeutic-grade genomic testing, and design rigorous implementations.
SOPHiA Radiomics for Oncology
It is a groundbreaking application that studies medical images (CT scans, MRI, or PET-CT), aggregating multiple data sources, including genomic, biological, and clinical data, to offer novel multimodal analyses for research purposes.
- Quick AI-powered 3D segmentation. Measurements of lesions, including volume, heterogeneity, and other imaging biomarkers.
- Central Oncoboard for disease monitoring.
- Novel multimodal predictive models for research purposes. (1)
SOPHiA Platform for Oncology
SOPHiA Platform is a technology for streamlined genomic data analysis, interpretation, and reporting in oncology. It allows advanced analytical performance and facilitates the visualization of genomic alterations associated with tumors and hematological malignancies.
- Turns data into actionable insights: SOPHiA platform offers multiple features for efficient and simplified assessment and visualization. Experts can filter down and report relevant candidates associated with a specific type of cancer.
- Advance analytical performance: The platform analyzes complex NGS data by detecting, annotating, and pre-classifying SNVS, Indels, and gene amplification in one experiment.
- Ensures data security: All data is encrypted and stored at rest with replication across geographically distant and secure data centers.
- Access SOPHiA’s community: Experts from hundreds of healthcare centers interpret the results and highlight the pathogenicity level of variants according to their knowledge and experience. This vital information feeds the variant knowledge base.
SOPHiA for clinical trials
- SOPHiA trial match: ensure accurate genomic analysis and provides engagement with the global clinical community increasing clinical trial efficiency.
- SOPHiA trial detection: Support clinical genomic network and accelerate turnaround time.
SOPHiA CDx: Build with top scientific experts and improve development and deployment.(2)
SOPHiA for clinical trials
- SOPHiA trial match: ensure accurate genomic analysis and provides engagement with the global clinical community increasing clinical trial efficiency.
- SOPHiA trial detection: Support clinical genomic network and accelerate turnaround time.
SOPHiA CDx: Build with top scientific experts and improve development and deployment.(2)
SOPHiA Genetics' financial aspects
SOPHiA Genetics announced the closing of a $110 million financing round to enter the next stage of its expansion, with a principal focus on supporting the growing clinical and biopharma demand for Data-Driven Medicine Worldwide.
The Series F round was led by aMoon, a leading health tech and life sciences venture fund based in Israel, and Hitachi Ventures. The company also received the trust of prime financial institutions Credit Suisse and the Pictet group. Existing investors participated in the round.
The new funding round will boost the company’s penetration in both the US and Asian markets. Proceeds will also be dedicated to increasing the platform’s multimodal capabilities and its adoption by healthcare institutions worldwide.
